GCL
KIN

Glazer Capital LLC’s Kindred Biosciences, Inc. KIN Stock Holding History

Glazer Capital LLC’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-454,164
Closed -$4.17M – 1164
2021
Q2 		$4.17M Buy
+454,164
New +$2.64M 0.06% 333

Other funds holding KIN

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Glazer Capital LLC's KIN Position: Q3 2021 in Review

Glazer Capital LLC sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 454,164 shares — an estimated $4.17M sold.

Glazer Capital LLC first reported a position in KIN in Q2 2021 and held it in 1 quarter. The position peaked at $4.17M in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

  • Glazer Capital LLC reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Glazer Capital LLC sold 454,164 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $4.17M.
  • Glazer Capital LLC first reported a position in Kindred Biosciences, Inc. in Q2 2021 and held it in 1 quarter.
  • Glazer Capital LLC's Kindred Biosciences, Inc. position peaked at $4.17M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Glazer Capital LLC's 13F filing for Q3 2021, filed 15 Nov 2021.